Drug Database
Back to search

France· FR:68975699

REBIF 44 microgrammes, solution injectable en stylo prérempli

A interferon beta-1a product containing interféron bêta-1a, registered in France by MERCK SERONO EUROPE (ROYAUME-UNI), on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC L03AB07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedREBIF 44 microgrammes, solution injec…ATCL03AB07REGISTER NO.FR:68975699PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about interféron bêta-1aAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Interferon beta-1a is registered in 14 of 19 countries.

Countries holding a registration under ATC L03AB07 (interferon beta-1a), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search interferon beta-1a products by name

Interferon beta-1a · ATC L03AB07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of interferon beta-1a costs, country by country.

Normalised to the WHO defined daily dose (4.3 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Interferon beta-1a · price per daily dose (4.3 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$13.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
INTERFÉRON BÊTA-1A
Manufacturer
MERCK SERONO EUROPE (ROYAUME-UNI)
Country
France (FR)
ATC code
L03AB07
ATC class
Interferon beta-1a
Defined daily dose
4.3 mcg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400922190914
    12 seringue(s) préremplie(s) en verre de 0,5 ml dans stylo jetable avec aiguille(s) acier
    EUR 619.06

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

347 interactions on record for interferon beta-1a.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check interferon beta-1a against other medicinesHow interaction checks work

Interferon beta-1a · interactions on record

347 records

  • 15 severe
  • 332 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • ZidovudineJ05AF01severe
  • ClotrimazoleA01AB18moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Interferon beta-1a in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All interferon beta-1a products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Avonex, Rebif
  • Liechtenstein · Avonex, Rebif
  • Norway · Avonex, Rebif

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bbac7d7c-699e-4ce8-9fc3-d1a6ecd52238
GET /v1/drugs/bbac7d7c-699e-4ce8-9fc3-d1a6ecd52238?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68975699",
  "date_amm": "2010-06-02",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/98/063",
  "substance": "INTERFÉRON BÊTA-1A",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about interferon beta-1a.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console